These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27790945)

  • 1. Functionalization of nanostructures for antibiotic improvement: an interdisciplinary approach.
    Saúde A; Franco OL
    Ther Deliv; 2016 Nov; 7(11):761-771. PubMed ID: 27790945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoformulated antibiotics: the next step for pathogenic bacteria control.
    Saúde AC; Cherobim MD; Amaral AC; Dias SC; Franco OL
    Curr Med Chem; 2013; 20(10):1232-40. PubMed ID: 23432585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery.
    Li LL; Xu JH; Qi GB; Zhao X; Yu F; Wang H
    ACS Nano; 2014 May; 8(5):4975-83. PubMed ID: 24716550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics.
    Diab R; Khameneh B; Joubert O; Duval R
    Curr Pharm Des; 2015; 21(28):4095-105. PubMed ID: 26420233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides.
    Sandreschi S; Piras AM; Batoni G; Chiellini F
    Nanomedicine (Lond); 2016 Jul; 11(13):1729-44. PubMed ID: 27348155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
    Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology based anti-infectives to fight microbial intrusions.
    Rai M; Ingle AP; Gaikwad S; Gupta I; Gade A; Silvério da Silva S
    J Appl Microbiol; 2016 Mar; 120(3):527-42. PubMed ID: 26599354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.
    Zhang J; Liu M; Guo H; Gao S; Hu Y; Zeng G; Yang D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1968. PubMed ID: 38772565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics.
    Santos RS; Figueiredo C; Azevedo NF; Braeckmans K; De Smedt SC
    Adv Drug Deliv Rev; 2018; 136-137():28-48. PubMed ID: 29248479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief overview on nano-sized materials used in the topical treatment of skin and soft tissue bacterial infections.
    Salatin S; Lotfipour F; Jelvehgari M
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1313-1331. PubMed ID: 31738622
    [No Abstract]   [Full Text] [Related]  

  • 16. Delivery of antibiotics with polymeric particles.
    Xiong MH; Bao Y; Yang XZ; Zhu YH; Wang J
    Adv Drug Deliv Rev; 2014 Nov; 78():63-76. PubMed ID: 24548540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoantibiotics: a new paradigm for the treatment of surgical infection.
    Fernandez-Moure JS; Evangelopoulos M; Colvill K; Van Eps JL; Tasciotti E
    Nanomedicine (Lond); 2017 Jun; 12(11):1319-1334. PubMed ID: 28520517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance and nanotechnology: A narrative review.
    Zhu X; Tang Q; Zhou X; Momeni MR
    Microb Pathog; 2024 Aug; 193():106741. PubMed ID: 38871198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-vehicles give new lease of life to existing antimicrobials.
    Mela I; Kaminski CF
    Emerg Top Life Sci; 2020 Dec; 4(6):555-566. PubMed ID: 33258900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.